Genprex Inc. (GNPX)

AI Score

Unlock

0.27

0.01 (1.89%)

At close: Apr 11, 2025, 3:59 PM

0.27

0.78%

After-hours: Apr 11, 2025, 05:47 PM EDT

Dividends

No dividend history available for Genprex Inc..

Pro Subscription

Upgrade now for unlimited access to all data and tools.

Dividend Definition

Dividends are payments made by a company to its shareholders, typically derived from its profits. They represent a portion of earnings distributed to investors as a reward for holding shares. Dividends do not account for retained earnings or reinvestments and are therefore different from a company's total profits.

Related Stocks

Company	Dividend Yield

Dividend Rankings

GNPX News

1 year ago · Genprex (GNPX) Expands SCLC Study of Key Candidate, Stock Up - zacks.com
1 year ago · GENPREX (GNPX) Upgraded to Buy: Here's What You Should Know - zacks.com
1 year ago · Genprex granted Chinese patent for lead drug candidate REQORSA with PD-1 antibodies to treat cancers - proactiveinvestors.com
1 year ago · Genprex shares rise as FDA grants third Fast Track Designation for small cell lung cancer therapeutic REQORSA - proactiveinvestors.com
1 year ago · Genprex (GNPX) Up on Advancing Early-Stage NSCLC Study - zacks.com
1 year ago · Genprex wins approval to advance Phase 2 expansion of Acclaim-1 trial of REQORSA combined with Tagrisso in advanced non-small cell lung cancer - proactiveinvestors.com
1 year ago · Genprex says positive data from Acclaim-1 clinical trial to be published at 2023 ASCO meeting - proactiveinvestors.com
1 year ago · Penny Stocks To Buy? 10 Under $1 To Watch This Week - pennystocks.com
1 year ago · Genprex showcases unique potential of nonparticle delivery system at cancer conference; shares rise - proactiveinvestors.com
1 year ago · Genprex encouraged by latest reports on novel tumor suppressor - proactiveinvestors.com